The Leprosy Mission Nepal   Report issue

Foundation Phase 2
Founded: Lalitpur Nepal (1957)

Organization Overview

First Clinical Trial
2018
NCT03807362
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

The Leprosy Mission Nepal

Active Ingredients

Drugs in Phase 2 Trials (1)

cc-11050 (1 trial)

Drugs in Other Trials (2)

methotrexate (1 trial)

prednisolone (hydeltra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erythema (Phase 2)

Erythema Nodosum (Phase 2)

Leprosy (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3